Roy, S.; Laroche-Clary, A.; Verbeke, S.; Derieppe, M.-A.; Italiano, A.
MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers 2020, 12, 2253.
https://doi.org/10.3390/cancers12082253
AMA Style
Roy S, Laroche-Clary A, Verbeke S, Derieppe M-A, Italiano A.
MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers. 2020; 12(8):2253.
https://doi.org/10.3390/cancers12082253
Chicago/Turabian Style
Roy, Shomereeta, Audrey Laroche-Clary, Stephanie Verbeke, Marie-Alix Derieppe, and Antoine Italiano.
2020. "MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies" Cancers 12, no. 8: 2253.
https://doi.org/10.3390/cancers12082253
APA Style
Roy, S., Laroche-Clary, A., Verbeke, S., Derieppe, M.-A., & Italiano, A.
(2020). MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Cancers, 12(8), 2253.
https://doi.org/10.3390/cancers12082253